The use of simulated and indirect treatment comparison methods to evaluate therapies’ comparative effectiveness: an interview with Gabriel Tremblay
In this feature, Gabriel Tremblay (Purple Squirrel Economics Ltd.; NY, USA) shares his expert insight on the use of simulated and indirect treatment comparison (STC and ITC respectively) methods in cost–effectiveness research.
Please sign in or register for FREE
Sign in to The Evidence Base®
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>